Announcements Trials
Browse Landscape

Status

Recruiting 1

Sponsor Class

OTHER 1

Study Type

Observational 1

Sponsor

Cancer Type

Myeloid 1

Conditions

Myelodysplastic Syndromes 77Leukemia, Myeloid, Acute 72Leukemia, Myelogenous, Chronic, BCR-ABL Positive 34Myeloproliferative Disorders 33Precursor Cell Lymphoblastic Leukemia-Lymphoma 29Lymphoma, Non-Hodgkin 21Primary Myelofibrosis 18Leukemia, Myelomonocytic, Chronic 17Hodgkin Disease 15Leukemia 14Myelodysplastic-Myeloproliferative Diseases 12Polycythemia Vera 10Leukemia, Biphenotypic, Acute 10Histiocytosis, Langerhans-Cell 10Anemia, Refractory, with Excess of Blasts 10Sarcoma 9Neuroblastoma 9Multiple Myeloma 9Leukemia, Lymphocytic, Chronic, B-Cell 9Glioma 9Wilms Tumor 8Rhabdoid Tumor 8Neuroectodermal Tumors, Primitive, Peripheral 8Medulloblastoma 8Hepatoblastoma 8Ependymoma 8Blast Crisis 8Thrombocythemia, Essential 7Rhabdomyosarcoma 7Osteosarcoma 7

Interventions

Blood Specimen Collection 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Thrombosis × Myeloid × 30 days × Clear all
NCT06480591 2026-05-22

Evaluation of the Pathobiology of CALR-mutated MPN Cells

Wake Forest University Health Sciences

Recruiting
35 enrolled
Myeloid

Myeloproliferative Disorders, Thrombosis

Data powered by HemOnc (CC BY 4.0) Colophon âš¡